DATABASE
Home
Database
Who We Are
What We Offer
Register
Sign In
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Category
IntelGenx Secures Leadership Succession
News
IntelGenx Submits New Drug Application for Anti-Migraine VersaFilm(TM)
News
Intelgenx Technologies
Fund
IntelGenx Technologies Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan
News
IntelGenx to Present at Roth Capital Partners 25th Annual Growth Stock Conference
News
Inteliquent Sells Global Data Business to GTT for $54.5 Million
News
Intellectual Capital Group Ltd
Fund
Intellectual Property Exchange International (IPXI®) to Announce First Offering on June 5 Public Webinar
News
Intellectual Property: Hype Or Real Deal?
News
Intelligence Solutions: 4 Stocks To Watch
News
Intelligent Energy Powers Its Future With ANSYS Simulation
News
Intelligent Energy, Dyson Technology, Ricardo UK and TRW Conekt deliver enhanced fuel cells
News
Intelligent Investor Funds
Bank
IntelliPharmaCeutics
Fund
Intellipharmaceutics Announces First Quarter 2013 Results
News
Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates
News
Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)
News
Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference
News
Intellipharmaceutics Closes US$1.5 Million Convertible Debenture Financing
News
Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units
News
Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference
News
Intellipharmaceutics to Raise US$3.1 Million
News
Intelliseed Trials in China
News
Intellivate Capital
Fund
Intelsat Bermuda 11.5%
Company
Page 181 of 354